{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T23:07:56Z","timestamp":1789945676559,"version":"4.0.1"},"reference-count":60,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2014,1,1]],"date-time":"2014-01-01T00:00:00Z","timestamp":1388534400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,1,1]],"date-time":"2014-01-01T00:00:00Z","timestamp":1388534400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urologic Oncology: Seminars and Original Investigations"],"published-print":{"date-parts":[[2014,1]]},"DOI":"10.1016\/j.urolonc.2012.10.002","type":"journal-article","created":{"date-parts":[[2013,2,19]],"date-time":"2013-02-19T12:12:39Z","timestamp":1361275959000},"page":"28.e11-28.e20","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["Molecular aspects of upper tract urothelial carcinoma"],"prefix":"10.1016","volume":"32","author":[{"given":"Nilay","family":"Patel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manit","family":"Arya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asif","family":"Muneer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom","family":"Powles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Sullivan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Hines","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Kelly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.urolonc.2012.10.002_bib1","doi-asserted-by":"crossref","unstructured":"Roupret M, Zigeuner R, Palou J, et al. European guidelines for the diagnosis and management of upper urinary tract urothelial cell carcinomas. [2011 update]. Eur Urol 2011;59:584\u201394.","DOI":"10.1016\/j.eururo.2010.12.042"},{"key":"10.1016\/j.urolonc.2012.10.002_bib2","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1016\/j.eururo.2009.07.002","article-title":"Impact of tumor location on prognosis for patients with upper tract urothelial carcinoma managed by radical nephroureterectomy","volume":"57","author":"Raman","year":"2010","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2012.10.002_bib3","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1016\/j.eururo.2011.05.049","article-title":"Ureteral and multifocal tumours have worse prognosis than renal pelvic tumours in urothelial carcinoma of the upper urinary tract treated by nephroureterectomy","volume":"60","author":"Ouzzane","year":"2011","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2012.10.002_bib4","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1002\/cncr.24135","article-title":"Outcomes of radical nephroureterectomy: a series from the Upper Tract Urothelial Carcinoma Collaboration","volume":"115","author":"Margulis","year":"2009","journal-title":"Cancer"},{"key":"10.1016\/j.urolonc.2012.10.002_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.eururo.2012.02.018","article-title":"Stage-specific impact of tumor location on oncologic outcomes in patients with upper and lower tract urothelial carcinoma following radical surgery","author":"Rink","year":"2012","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2012.10.002_bib6","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1016\/j.juro.2009.05.011","article-title":"Adjuvant chemotherapy for high risk upper tract urothelial carcinoma: results from the Upper Tract Urothelial Carcinoma Collaboration","volume":"182","author":"Hellenthal","year":"2009","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2012.10.002_bib7","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1111\/j.1464-410X.2009.08838.x","article-title":"Environmental factors involved in carcinogenesis of urothelial cell carcinomas of the upper urinary tract","volume":"104","author":"Colin","year":"2009","journal-title":"Brit J Urol Int"},{"key":"10.1016\/j.urolonc.2012.10.002_bib8","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/S0140-6736(06)69079-X","article-title":"Chinese herbal uropathy and nephropathy","volume":"368","author":"Laing","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.urolonc.2012.10.002_bib9","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1038\/ki.2008.125","article-title":"Biotransformation enzymes in development of renal injury and urothelial cancer caused by aristolochic acid","volume":"73","author":"Stiborov\u00e1","year":"2008","journal-title":"Kidney Int"},{"key":"10.1016\/j.urolonc.2012.10.002_bib10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.mrfmmm.2009.01.005","article-title":"p53 mutations as fingerprints for aristolochic acid: an environmental carcinogen in endemic (Balkan) nephropathy","volume":"663","author":"Slade","year":"2009","journal-title":"Mutat Res"},{"key":"10.1016\/j.urolonc.2012.10.002_bib11","first-page":"384","article-title":"Identification of NQO1 and GSTs genotype frequencies in Bulgarian patients with Balkan endemic nephropathy","volume":"17","author":"Toncheva","year":"2004","journal-title":"J Nephrol"},{"key":"10.1016\/j.urolonc.2012.10.002_bib12","doi-asserted-by":"crossref","first-page":"2500","DOI":"10.1158\/1055-9965.EPI-07-0361","article-title":"Phenol sulfotransferase SULT1A1*2 allele and enhanced risk of upper urinary tract urothelial cell carcinoma","volume":"16","author":"Roupret","year":"2007","journal-title":"Cancer Epidemiol Biomarker Prev"},{"key":"10.1016\/j.urolonc.2012.10.002_bib13","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0165-4608(00)00426-X","article-title":"Comparative genomic hybridization analysis of transitional cell carcinomas of the renal pelvis","volume":"127","author":"Rigola","year":"2001","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/j.urolonc.2012.10.002_bib14","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1038\/sj.onc.1202385","article-title":"Superimposed histologic and genetic mapping of chromosome 9 in progression of human urinary bladder neoplasia: implications for a genetic model of multistep urothelial carcinogenesis and early detection of urinary bladder cancer","volume":"18","author":"Czerniak","year":"1999","journal-title":"Oncogene"},{"key":"10.1016\/j.urolonc.2012.10.002_bib15","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1002\/gcc.20803","article-title":"Identification of genetic alterations in upper urinary tract urothelial carcinoma in end-stage renal disease patients","volume":"49","author":"Wu","year":"2010","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.urolonc.2012.10.002_bib16","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/S0022-5347(01)62926-4","article-title":"Urinary tract cancer and hereditary nonpolyposis colorectal cancer: risks and screening options","volume":"160","author":"Sijmons","year":"1998","journal-title":"J Uro"},{"key":"10.1016\/j.urolonc.2012.10.002_bib17","article-title":"Patients with lynch syndrome mismatch repair gene mutations are at higher risk for not only upper tract urothelial cancer but also bladder cancer","author":"Skeldon","year":"2012","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2012.10.002_bib18","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/nrclinonc.2009.237","article-title":"Microsatellite instability in colorectal cancer-the stable evidence","volume":"7","author":"Vilar","year":"2010","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.urolonc.2012.10.002_bib19","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1016\/j.eururo.2008.08.008","article-title":"Upper urinary tract urothelial cell carcinomas and other urological malignancies involved in the hereditary nonpolyposis colorectal cancer (Lynch syndrome) tumor spectrum","volume":"54","author":"Roupret","year":"2008","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2012.10.002_bib20","doi-asserted-by":"crossref","first-page":"2903","DOI":"10.1200\/JCO.2005.03.163","article-title":"Promoter hypermethylation is associated with tumor location, stage, and subsequent progression in transitional cell carcinoma","volume":"23","author":"Catto","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.urolonc.2012.10.002_bib21","doi-asserted-by":"crossref","first-page":"6982","DOI":"10.1073\/pnas.1002472107","article-title":"Modulation of mismatch repair and genomic stability by miR-155","volume":"107","author":"Valeri","year":"2010","journal-title":"Proc Nat Acad Sci"},{"key":"10.1016\/j.urolonc.2012.10.002_bib22","doi-asserted-by":"crossref","first-page":"8699","DOI":"10.1038\/sj.onc.1206964","article-title":"Distinct patterns of microsatellite instability are seen in tumours of the urinary tract","volume":"22","author":"Catto","year":"2003","journal-title":"Oncogene"},{"key":"10.1016\/j.urolonc.2012.10.002_bib23","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1053\/hupa.2003.22","article-title":"Urothelial carcinoma of the upper urinary tract: inverted growth pattern is predictive of microsatellite instability","volume":"34","author":"Hartmann","year":"2003","journal-title":"Hum Pathol"},{"key":"10.1016\/j.urolonc.2012.10.002_bib24","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1016\/j.urology.2005.01.019","article-title":"Microsatellite instability as predictor of survival in patients with invasive upper urinary tract transitional cell carcinoma","volume":"65","author":"Roupr\u00eat","year":"2005","journal-title":"Urology"},{"key":"10.1016\/j.urolonc.2012.10.002_bib25","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1046\/j.1464-410x.2000.00726.x","article-title":"Prognostic significance of p27Kip1 and Ki-67 expression in carcinoma of the renal pelvis and ureter","volume":"86","author":"Kamai","year":"2000","journal-title":"Brit J Urol Int"},{"key":"10.1016\/j.urolonc.2012.10.002_bib26","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1016\/j.urology.2004.01.009","article-title":"Prognostic impact of p63 and p53 expression in upper urinary tract transitional cell carcinoma","volume":"63","author":"Zigeuner","year":"2004","journal-title":"Urology"},{"key":"10.1016\/j.urolonc.2012.10.002_bib27","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1111\/j.1464-410X.2010.09210.x","article-title":"Nuclear factor-\u03baB activation predicts an unfavourable outcome in human upper urinary tract urothelial carcinoma","volume":"106","author":"Yeh","year":"2010","journal-title":"Brit J Urol Int"},{"key":"10.1016\/j.urolonc.2012.10.002_bib28","article-title":"Impact of the expression of Aurora-A, p53, and Mib-1 on the prognosis of urothelial carcinomas of the upper urinary tract","author":"Scarpini","year":"2011","journal-title":"Urology"},{"key":"10.1016\/j.urolonc.2012.10.002_bib29","doi-asserted-by":"crossref","first-page":"7004","DOI":"10.1158\/1078-0432.CCR-06-0825","article-title":"Chromosome 20q13.2 gain may predict intravesical recurrence after nephroureterectomy in upper urinary tract urothelial tumors","volume":"12","author":"Akao","year":"2006","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.urolonc.2012.10.002_bib30","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1016\/j.urology.2009.04.088","article-title":"Expression of stathmin in localized upper urinary tract urothelial carcinoma: correlations with prognosis","volume":"74","author":"Lin","year":"2011","journal-title":"Urology"},{"key":"10.1016\/j.urolonc.2012.10.002_bib31","doi-asserted-by":"crossref","first-page":"296","DOI":"10.3346\/jkms.2008.23.2.296","article-title":"Impact of caveolin-1 expression on the prognosis of transitional cell carcinoma of the upper urinary tract","volume":"23","author":"Cho","year":"2008","journal-title":"J Korean Med Sci"},{"key":"10.1016\/j.urolonc.2012.10.002_bib32","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.humpath.2008.10.010","article-title":"Prognostic value of apoptosis-related markers in urothelial cancer of the upper urinary tract","volume":"40","author":"Md","year":"2009","journal-title":"Hum Pathol"},{"key":"10.1016\/j.urolonc.2012.10.002_bib33","doi-asserted-by":"crossref","first-page":"513.e7","DOI":"10.1016\/j.urology.2010.03.070","article-title":"Expression of Ki-67 and COX-2 in patients with upper urinary tract urothelial carcinoma","volume":"76","author":"Jeon","year":"2011","journal-title":"Urology"},{"key":"10.1016\/j.urolonc.2012.10.002_bib34","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/j.urology.2008.11.060","article-title":"Prognostic relevance of prothymosin-\u03b1 expression in human upper urinary tract transitional cell carcinoma","volume":"74","author":"Jou","year":"2011","journal-title":"Urology"},{"key":"10.1016\/j.urolonc.2012.10.002_bib35","first-page":"58","article-title":"Comparative gene expression profiling analysis of urothelial carcinoma of the renal pelvis and bladder","volume":"3","author":"Zhang","year":"2010","journal-title":"Bioorg Med Chem Med Genomics"},{"key":"10.1016\/j.urolonc.2012.10.002_bib36","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1007\/s00428-007-0457-9","article-title":"Expression of LAT1 predicts risk of progression of transitional cell carcinoma of the upper urinary tract","volume":"451","author":"Nakanishi","year":"2007","journal-title":"Virchows Arch"},{"key":"10.1016\/j.urolonc.2012.10.002_bib37","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1111\/j.1464-410X.2009.09144.x","article-title":"Glucose-regulated protein 78 expression in urothelial carcinoma of the upper urinary tract","volume":"106","author":"Uematsu","year":"2010","journal-title":"Brit J Urol Int"},{"key":"10.1016\/j.urolonc.2012.10.002_bib38","doi-asserted-by":"crossref","first-page":"8256","DOI":"10.1158\/0008-5472.CAN-09-1689","article-title":"Activation of the PI3K\/AKT pathway induces urothelial carcinoma of the renal pelvis: identification in human tumors and confirmation in animal models","volume":"69","author":"Qian","year":"2009","journal-title":"Cancer Res"},{"key":"10.1016\/j.urolonc.2012.10.002_bib39","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/j.eururo.2008.06.013","article-title":"FGFR3 mutations indicate better survival in invasive upper urinary tract and bladder tumours","volume":"55","author":"van Oers","year":"2009","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2012.10.002_bib40","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1093\/carcin\/bgp222","article-title":"Activation of the aryl hydrocarbon receptor pathway enhances cancer cell invasion by upregulating the MMP expression and is associated with poor prognosis in upper urinary tract urothelial cancer","volume":"31","author":"Ishida","year":"2010","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.urolonc.2012.10.002_bib41","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1097\/01.ju.0000148272.77539.2d","article-title":"Expression of cyclooxygenase-2 and EP4 receptor in transitional cell carcinoma of the upper urinary tract","volume":"173","author":"Miyata","year":"2005","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2012.10.002_bib42","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.urology.2004.08.025","article-title":"HER2 protein overexpression and gene amplification in upper urinary tract transitional cell carcinoma: systematic analysis applying tissue microarray technique","volume":"65","author":"Langner","year":"2005","journal-title":"Urology"},{"key":"10.1016\/j.urolonc.2012.10.002_bib43","doi-asserted-by":"crossref","first-page":"2583","DOI":"10.1158\/1078-0432.CCR-04-1685","article-title":"Expression of hypoxia-inducible factor-1 protein predicts survival in patients with transitional cell carcinoma of the upper urinary tract","volume":"11","author":"Nakanishi","year":"2005","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.urolonc.2012.10.002_bib44","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1111\/j.1442-2042.2007.01978.x","article-title":"Overexpression of hypoxia-inducible factor-1\u03b1 predicts an unfavorable outcome in urothelial carcinoma of the upper urinary tract","volume":"15","author":"Ke","year":"2008","journal-title":"Int J Urol"},{"key":"10.1016\/j.urolonc.2012.10.002_bib45","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1016\/j.eururo.2005.07.005","article-title":"Tissue microarray analysis of the prognostic value of E-cadherin, Ki67, p53, p27, survivin and MSH2 expression in upper urinary tract transitional cell carcinoma","volume":"48","author":"Fromont","year":"2005","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2012.10.002_bib46","first-page":"1863","article-title":"The prognostic value of angiogenesis and metastasis-related genes for progression of transitional cell carcinoma of the renal pelvis and ureter","volume":"8","author":"Inoue","year":"2002","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.urolonc.2012.10.002_bib47","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1038\/sj.bjc.6605835","article-title":"Expression of parvin-\u03b2 is a prognostic factor for patients with urothelial cell carcinoma of the upper urinary tract","volume":"103","author":"Wu","year":"2010","journal-title":"Brit J Cancer"},{"key":"10.1016\/j.urolonc.2012.10.002_bib48","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/j.urology.2003.09.035","article-title":"Expression of metalloproteinase-2, metalloproteinase-9, and tissue inhibitor of metalloproteinase-1 in transitional cell carcinoma of upper urinary tract: correlation with tumor stage and survival","volume":"63","author":"Miyata","year":"2004","journal-title":"Urology"},{"key":"10.1016\/j.urolonc.2012.10.002_bib49","doi-asserted-by":"crossref","first-page":"5814","DOI":"10.1158\/1078-0432.CCR-10-0230","article-title":"Expression of Snail in upper urinary tract urothelial carcinoma: prognostic significance and implications for tumor invasion","volume":"16","author":"Kosaka","year":"2010","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.urolonc.2012.10.002_bib50","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1111\/j.1464-410X.2006.06158.x","article-title":"Loss of uroplakin III expression is associated with a poor prognosis in patients with urothelial carcinoma of the upper urinary tract","volume":"97","author":"Ohtsuka","year":"2006","journal-title":"Brit J Urol Int"},{"key":"10.1016\/j.urolonc.2012.10.002_bib51","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1093\/carcin\/bgs025","article-title":"Urothelial tumor initiation requires deregulation of multiple signaling pathways: implications in target-based therapies","volume":"33","author":"Zhou","year":"2012","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.urolonc.2012.10.002_bib52","doi-asserted-by":"crossref","first-page":"3463","DOI":"10.1158\/0008-5472.CAN-09-4213","article-title":"Combined gene expression and genomic profiling define two intrinsic molecular subtypes of urothelial carcinoma and gene signatures for molecular grading and outcome","volume":"70","author":"Lindgren","year":"2010","journal-title":"Cancer Res"},{"key":"10.1016\/j.urolonc.2012.10.002_bib53","doi-asserted-by":"crossref","first-page":"e38863","DOI":"10.1371\/journal.pone.0038863","article-title":"Integrated genomic and gene expression profiling identifies two major genomic circuits in urothelial carcinoma","volume":"7","author":"Lindgren","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.urolonc.2012.10.002_bib54","doi-asserted-by":"crossref","first-page":"e38972","DOI":"10.1371\/journal.pone.0038972","article-title":"FGFR1-induced epithelial to mesenchymal transition through MAPK\/PLC\u03b3\/COX-2-mediated mechanisms","volume":"7","author":"Tomlinson","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.urolonc.2012.10.002_bib55","doi-asserted-by":"crossref","first-page":"e18583","DOI":"10.1371\/journal.pone.0018583","article-title":"A systematic study of gene mutations in urothelial carcinoma; inactivating mutations in TSC2 and PIK3R1","volume":"6","author":"Sj\u00f6dahl","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1016\/j.urolonc.2012.10.002_bib56","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s11912-012-0225-0","article-title":"FGF receptor inhibitors: role in cancer therapy","volume":"14","author":"Daniele","year":"2012","journal-title":"Curr Oncol Rep"},{"key":"10.1016\/j.urolonc.2012.10.002_bib57","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1038\/labinvest.2010.133","article-title":"Expanding therapeutic targets in bladder cancer: the PI3K\/Akt\/mTOR pathway","volume":"90","author":"Ching","year":"2010","journal-title":"Lab Invest"},{"key":"10.1016\/j.urolonc.2012.10.002_bib58","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1158\/1535-7163.MCT-11-0756","article-title":"New directions for biologic targets in urothelial carcinoma","volume":"11","author":"Richter","year":"2012","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.urolonc.2012.10.002_bib59","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.eururo.2008.05.001","volume":"55","author":"van der Aa","year":"2009","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2012.10.002_bib60","doi-asserted-by":"crossref","unstructured":"Audenet F, Colin P, Yates DR et al.: A proportion of hereditary upper urinary tract urothelial carcinomas are misclassified as sporadic according to a multi-institutional database analysis: proposal of patient-specific risk identification tool. Brit J Urol Int 2012; http:\/\/dx.doi.org\/10.1111\/j.1464-410X.2012.11298.x.","DOI":"10.1111\/j.1464-410X.2012.11298.x"}],"container-title":["Urologic Oncology: Seminars and Original Investigations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143912003481?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143912003481?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T10:06:05Z","timestamp":1761041165000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1078143912003481"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,1]]},"references-count":60,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,1]]}},"alternative-id":["S1078143912003481"],"URL":"https:\/\/doi.org\/10.1016\/j.urolonc.2012.10.002","relation":{},"ISSN":["1078-1439"],"issn-type":[{"value":"1078-1439","type":"print"}],"subject":[],"published":{"date-parts":[[2014,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Molecular aspects of upper tract urothelial carcinoma","name":"articletitle","label":"Article Title"},{"value":"Urologic Oncology: Seminars and Original Investigations","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urolonc.2012.10.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}